Media coverage about Rite Aid (NYSE:RAD) has trended somewhat positive on Thursday, according to Accern. The research firm identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Rite Aid earned a news sentiment score of 0.09 on Accern’s scale. Accern also assigned news stories about the company an impact score of 44.2679818774214 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the media headlines that may have effected Accern’s scoring:

How to Become a New Pot Stock Millionaire

Shares of Rite Aid stock opened at $1.54 on Thursday. The company has a market capitalization of $1,686.88, a price-to-earnings ratio of 10.27 and a beta of 1.79. Rite Aid has a fifty-two week low of $1.38 and a fifty-two week high of $4.87. The company has a current ratio of 0.86, a quick ratio of 0.59 and a debt-to-equity ratio of 3.66.

A number of research analysts have recently weighed in on the company. Zacks Investment Research lowered Rite Aid from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. Vetr lowered Rite Aid from a “strong-buy” rating to a “buy” rating and set a $2.47 target price on the stock. in a report on Thursday, January 11th. Evercore ISI began coverage on Rite Aid in a report on Thursday, January 4th. They issued an “underperform” rating and a $1.50 target price on the stock. Finally, Deutsche Bank began coverage on Rite Aid in a report on Monday, December 4th. They set a “hold” rating and a $2.25 price target on the stock. Two investment analysts have rated the stock with a sell rating, six have given a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $2.33.

COPYRIGHT VIOLATION WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Rite Aid (RAD) Share Price” was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.watchlistnews.com/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-rite-aid-rad-share-price/1955170.html.

Rite Aid Company Profile

Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.

Insider Buying and Selling by Quarter for Rite Aid (NYSE:RAD)

Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.